The answerable question and a hierarchy of evidence

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 44, Issue 6, 2005, Pages 596-600

  Hamilton, John ^a,b  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; CLINICAL PRACTICE; COMPUTER PROGRAM; EVIDENCE BASED MEDICINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TREATMENT PLANNING;

EID: 19344362953     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000155315.17801.05     Document Type: Article

References (15)

1. Altman D, Schulz K, Moher D et al. (2001), The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134:663-694
2. Gliner JA, Morgan GA, Harmon RJ (2000), Introduction to inferential statistics and hypothesis testing. J Am Acad Child Adolesc Psychiatry 39:1568-1570
3. Greenhill LL, Abikoff HB, Arnold LE et al. (1996), Medication treatment strategies in the MTA study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 35:1304-1313
4. Guyatt G, Jaeschke R, McGinn T (2002a), Therapy and validity: N of 1 randomized controlled trials. In: Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, Guyatt G, Rennie D, eds. Chicago: AMA Press, pp 275-290
5. Guyatt G, Sinclair J, Cook DJ, Jaeschke R, Schunemann H, Pauker S (2002b), Moving from evidence to action: grading recommendations - a qualitative approach. In: Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, Guyatt G, Rennie D, eds. Chicago: AMA Press, pp 567-658
6. Haynes B, Devereaux P, Guyatt G (2002), Clinical expertise in the era of evidence-based medicine and patient choice. ACP J Club 136:A11
7. Kent MA, Camfield CS, Camfield PR (1999), Double-blind methylphenidate trials: practical, useful, and highly endorsed by families. Arch Pediatr Adolesc Med 153:1292-1296
8. Kratochvil CJ, Heiligenstein JH, Dittmann R et al. (2002), Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolesc Psychiatry 41:776-784
9. McKibbon A, Hunt D, Richardson WS et al. (2002a), Finding the evidence. In: Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, Guyatt GH, Rennie D, eds. Chicago: AMA Press, pp 13-47
10. McKibbon A, Hunt D, Richardson WS et al. (2002b), Introduction: the philosophy of evidence-based medicine. In: Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, Guyatt G, Rennie D, eds. Chicago: AMA Press, pp 3-12
11. Michelson D, Faries D, Wernicke J et al. (2001), Atomoxetine in the treatment of children and adolescents with ADHD: a randomized, placebo-controlled dose-response study. Pediatrics 108:E83
12. Oxman AD, Guyatt G, Cook DJ, Montori V (2002), Summarizing the evidence. In: Users' Guide to the Medical Literature: A Manual for Evidence-Based Clinical Practice, Guyatt G, Rennie D, eds. Chicago: AMA Press, pp 155-174
13. Sackett D, Straus S, Richardson W, Rosenberg W, Haynes R (2000), Evidence-Based Medicine: How to Practice and Teach EBM. London: Churchill Livingstone
14. Swanson J (2004), SWAN and SNAP-IV Rating Scales' Site; http://www.adhd.net (accessed October 30, 2004)
15. Wilens TE (2003), Treatment of refractory ADHD. Advanced psychopharmacology for clinical practice. Presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry, Miami